Concepedia

Geoffrey Stemp

GS

57

Publications

2.9K

Citations

29

H-Index

1977

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Molecular Discovery (United Kingdom)

New Frontier

University of Manchester

Geoffrey Stemp is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1977–2011

57

Publications

57

Pharmacological Actions of a Novel, High-Affinity, and Selective Human Dopamine D3 Receptor Antagonist, SB-277011-A

C. Reavill, Stephen G. Taylor, Martyn Wood et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 288 citations · Full text

Dopamine D<sub>3</sub>Receptor Antagonism Inhibits Cocaine-Seeking and Cocaine-Enhanced Brain Reward in Rats

Stanislav R. Vorel, Charles R. Ashby, Mousumi Paul et al. · Journal of Neuroscience · 2002 · 268 citations · Full text

Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyrans

Valerie A. Ashwood, Robin E. Buckingham, Frederick Cassidy et al. · Journal of Medicinal Chemistry · 1986 · 170 citations

, , +14

Directed Dihydroxylation of Cyclic Allylic Alcohols and Trichloroacetamides Using OsO<sub>4</sub>/TMEDA

Timothy J. Donohoe, Kevin Blades, Peter R. Moore et al. · The Journal of Organic Chemistry · 2002 · 138 citations

, , +9

Discovery of SB-705498: A potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development

Harshad K. Rami, Mervyn Thompson, Geoffrey Stemp et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 132 citations · Full text

, , +6

Rows per page

1–5 of 57